DFDA

Docetaxel + Cisplatin + 5-Fluorouracil (TPF Induction Chemotherapy) followed by Concurrent Chemoradiotherapy

Treatment for Nasopharynx Cancer

Typical Dosage: Docetaxel 75 mg/m2, Cisplatin 75 mg/m2, 5-Fluorouracil 750 mg/m2/day continuous infusion for 5 days, every 3 weeks for 3 cycles. Followed by Cisplatin-based CCRT (66-70 Gy radiation with weekly Cisplatin 40 mg/m2).

Effectiveness
89%
Safety Score
20%
Clinical Trials
3
Participants
8K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
20
DangerousModerateSafe
Treatment Details
Dosage Range
Docetaxel 75 mg/m2, Cisplatin 75 mg/m2, 5-Fluorouracil 750 mg/m2/day continuous infusion for 5 days, every 3 weeks for 3 cycles. Followed by Cisplatin-based CCRT (66-70 Gy radiation with weekly Cisplatin 40 mg/m2).
Time to Effect
Within weeks for induction; full effect after CCRT (months)
Treatment Duration
4-5 months (9 weeks induction + 6-7 weeks CCRT)
Evidence Quality
HIGH
Confidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$20,000
Monitoring:$30,000
Side Effect Mgmt:$25,000
Total Annual:$75,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATE
QALYs Gained
2.7
Outcome-Based Costs
Cost per Responder
$83,333
Cost per Remission
$91,463
Comparison vs Concurrent Chemoradiotherapy (Cisplatin-based)
Cost Difference
+$35,000/year
More expensive
QALY Difference
+0.70 QALYs
Better outcomes
Dominance
No dominance
Prescription Access Economics
Risk Assessment
Requires Monitoring
Yes
Needs lab work/checkups
Docetaxel + Cisplatin + 5-Fluorouracil (TPF Induction Chemotherapy) followed by Concurrent Chemoradiotherapy Outcomes

for Nasopharynx Cancer

Efficacy Outcomes
Overall Effectiveness
+89%
Response Rate
+90%
Remission Rate
+82%
Common Side Effects
Myelosuppression (Neutropenia)
+80%
Nausea/Vomiting
+85%
Mucositis
+50%
Diarrhea
+40%
Fatigue
+80%
Alopecia
+60%
Peripheral neuropathy
+25%

Sources:

researchgate.net
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov